Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan
Jamshid Gadoev(Central Bank of Uzbekistan), Masoud Dara(World Health Organization Regional Office for Europe), Askar Yedilbayev(World Health Organization Regional Office for Europe), Bakhtinur Khudanov(Ministry of Health of the Republic of Uzbekistan), Kallibek Kudaybergenov, Barno Abdusamatova(Ministry of Health of the Republic of Uzbekistan), Oleksandr Korotych(World Health Organization Regional Office for Europe), Arax Hovhannesyan(World Health Organization Regional Office for Europe), Martin J. Boeree(Radboud University Nijmegen), Lianne Kuppens(Central Bank of Uzbekistan), Anthony Harries(University of London), Damin Asadov(Tashkent Pediatric Medical Institute), Ajay Kumar(Chaudhary Charan Singh Haryana Agricultural University), Atadjan Hamraev(Tashkent Pediatric Medical Institute)
International Journal of Environmental Research and Public Health
December 5, 2021
Cited by 9
Related Papers
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639
Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis
|PLoS Medicine|2012|413
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
|The Lancet|2011|237
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
|International Journal of Infectious Diseases|2020|226
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
|European Respiratory Journal|2019|176